Furberg, Curt D.

The Cardiovascular Health Study: design and rationale.

Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 3,652

Fundamentals of Clinical Trials

Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · Springer eBooks

Statistical Methods in Clinical TrialsStatistical Methods in Epidemiology

Cited by 2,237

Incidence of and risk factors for atrial fibrillation in older adults

Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 1,462

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., Tunis, S., Bergel, E., Harvey, I., Magid, D. J., et al. (2009) · Journal of Clinical Epidemiology

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 1,389

Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis

Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine

Menopause: Health Impacts and TreatmentsEstrogen and related hormone effects

Cited by 1,242

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)

Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 1,096

Fundamentals of Clinical Trials

Friedman, L. M., Furberg, C. D., & DeMets, D. L. (1998) · Springer eBooks

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 873

Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians: A Scientific Statement From the American Heart Association

Antman, E. M., Bennett, J. S., Daugherty, A., Furberg, C., Roberts, H., & Taubert, K. A. (2007) · Circulation

Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 804

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

Armitage, J., Baigent, C., Barnes, E., Betteridge, D. J., Blackwell, L., Blazing, M., Bowman, L., Braunwald, E., Byington, R., Cannon, C., et al. (2019) · The Lancet

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 801

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 659

Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study

Mozaffarian, D., Furberg, C. D., Psaty, B. M., & Siscovick, D. (2008) · Circulation

Atrial Fibrillation Management and OutcomesPhysical Activity and Health

Cited by 476

Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study

Longstreth, W. T., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., Hirsch, C. H., O’Leary, D. H., & Furberg, C. D. (2005) · Stroke

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 474

Cholesterol Reduction Yields Clinical Benefit: Impact of Statin Trials

Gould, A. L., Rossouw, J. E., Santanello, N. C., Heyse, J. F., & Furberg, C. D. (1998) · Circulation

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 442

Withdrawal of Cerivastatin from the World Market

Furberg, C. D., & Pitt, B. (2001) · Trials

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 400

Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project

Sacks, F. M., Tonkin, A. M., Shepherd, J., Braunwald, E., Cobbe, S., Hawkins, C. M., Keech, A., Packard, C., Simes, J., Byington, R., et al. (2000) · Circulation

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 388

Assessment and Control for Confounding by Indication in Observational Studies

Psaty, B. M., Koepsell, T. D., Lin, D., Weiss, N. S., Siscovick, D. S., Rosendaal, F. R., Pahor, M., & Furberg, C. D. (1999) · Journal of the American Geriatrics Society

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 363

Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study

Longstreth, W. T., Dulberg, C., Manolio, T. A., Lewis, M. R., Beauchamp, N. J., O’Leary, D., Carr, J., & Furberg, C. D. (2002) · Stroke

Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disorders

Cited by 294

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

Singh, S., Loke, Y. K., Spangler, J. G., & Furberg, C. D. (2011) · Canadian Medical Association Journal

Smoking Behavior and CessationPharmacovigilance and Adverse Drug Reactions

Cited by 286

Cholesterol Reduction Yields Clinical Benefit: A New Look at Old Data

Gould, A. L., Rossouw, J. E., Santanello, N. C., Heyse, J. F., & Furberg, C. D. (1995) · Circulation

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 272

Thiazolidinediones and Heart Failure

Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · Diabetes Care

Diabetes Treatment and ManagementPharmacovigilance and Adverse Drug Reactions

Cited by 262

Heart and Estrogen/progestin Replacement Study (HERS)

Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials

Menopause: Health Impacts and TreatmentsEstrogen and related hormone effects

Cited by 260

Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)

Canner, P. L., Furberg, C. D., Terrin, M. L., & McGovern, M. E. (2005) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 226

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia

DeKosky, S. T., Fitzpatrick, A., Ives, D. G., Saxton, J., Williamson, J., Lopez, O. L., Burke, G., Fried, L., Kuller, L. H., Robbins, J., et al. (2006) · Contemporary Clinical Trials

Ginkgo biloba and Cashew ApplicationsDementia and Cognitive Impairment Research

Cited by 176

Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C

Pencina, M. J., D’Agostino, R. B., Zdrojewski, T., Williams, K., Thanassoulis, G., Furberg, C. D., Peterson, E. D., Vasan, R. S., & Sniderman, A. D. (2015) · European Journal of Preventive Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 164